These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 22344043)
1. p16 gene alterations in human ovarian cancers: comparison between tissue and blood samples. Bammidi LS; Neerukonda GN; Murthy S; Kanapuram RD Int J Gynecol Cancer; 2012 May; 22(4):553-60. PubMed ID: 22344043 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic alteration of p16 and retinoic acid receptor beta genes in the development of epithelial ovarian carcinoma. Bhagat R; Kumar SS; Vaderhobli S; Premalata CS; Pallavi VR; Ramesh G; Krishnamoorthy L Tumour Biol; 2014 Sep; 35(9):9069-78. PubMed ID: 24913706 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis. Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762 [TBL] [Abstract][Full Text] [Related]
4. Meta-analysis demonstrates no association between p16 Jiang Y; Yan F; Liang L; Wan Y; Liu J; Cheng W Arch Gynecol Obstet; 2017 Mar; 295(3):697-704. PubMed ID: 28000027 [TBL] [Abstract][Full Text] [Related]
5. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas. He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522 [TBL] [Abstract][Full Text] [Related]
6. Aberrant promoter hypermethylation of p16, survivin, and retinoblastoma in gastric cancer. Guo L; Huang C; Ji QJ Bratisl Lek Listy; 2017; 118(3):164-168. PubMed ID: 28319413 [TBL] [Abstract][Full Text] [Related]
7. Significance of beta-catenin and pRB pathway components in malignant ovarian germ cell tumours: INK4A promoter CpG island methylation is associated with cell proliferation. Kawauchi S; Liu XP; Kawasaki K; Hirakawa T; Amada S; Furuya T; Oga A; Sasaki K J Pathol; 2004 Nov; 204(3):268-76. PubMed ID: 15476271 [TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation profile of ovarian epithelial neoplasms. Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849 [TBL] [Abstract][Full Text] [Related]
9. Relationship between promoter methylation & tissue expression of MGMT gene in ovarian cancer. Shilpa V; Bhagat R; Premalata CS; Pallavi VR; Ramesh G; Krishnamoorthy L Indian J Med Res; 2014 Nov; 140(5):616-23. PubMed ID: 25579142 [TBL] [Abstract][Full Text] [Related]
10. Methylation status of the gene promoter of cyclin-dependent kinase inhibitor 2A (CDKN2A) in ovarian cancer. Abou-Zeid AA; Azzam AZ; Kamel NA Scand J Clin Lab Invest; 2011 Nov; 71(7):542-7. PubMed ID: 21728901 [TBL] [Abstract][Full Text] [Related]
11. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population. Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic and genetic alterations of p33ING1b in ovarian cancer. Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627 [TBL] [Abstract][Full Text] [Related]
13. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma]. Koscielny S; V Eggeling F; Dahse R Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677 [TBL] [Abstract][Full Text] [Related]
14. [Disfigurement of p16INK4A gene expression in development of ovarian cancer and the mechanism]. Li M; Huang ZJ; Dong WH; Li XY; Wang XY; He XH; Wang H; Wang ZH Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):408-12. PubMed ID: 16831366 [TBL] [Abstract][Full Text] [Related]
15. Alterations of the p16INK4A gene in human ovarian cancers. Kanuma T; Nishida J; Gima T; Barrett JC; Wake N Mol Carcinog; 1997 Mar; 18(3):134-41. PubMed ID: 9115583 [TBL] [Abstract][Full Text] [Related]
16. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer. Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590 [TBL] [Abstract][Full Text] [Related]
17. Lack of mutation at p16INK4A gene but expression of aberrant p16INK4A RNA transcripts in human ovarian carcinoma. Suh SI; Cho JW; Baek WK; Suh MH; Carson DA Cancer Lett; 2000 May; 153(1-2):175-82. PubMed ID: 10779647 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of the p16INK4A gene by methylation is not a frequent event in sporadic ovarian carcinoma. Brown I; Milner BJ; Rooney PH; Haites NE Oncol Rep; 2001; 8(6):1359-62. PubMed ID: 11605066 [TBL] [Abstract][Full Text] [Related]
19. Alterations of the p16(ink4a) gene in resected nonsmall cell lung tumors and exfoliated cells within sputum. Chen JT; Chen YC; Wang YC; Tseng RC; Chen CY; Wang YC Int J Cancer; 2002 Apr; 98(5):724-31. PubMed ID: 11920642 [TBL] [Abstract][Full Text] [Related]
20. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter]. Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]